Showing results (71-80 of 140) with videos related to

Sort By:
Pageof 14
Frontiers in Immunology|May 20, 2025
<i>TNFRSF12A</i> expression in stomach adenocarcinoma and its preliminary role in predicting immunotherapy responseLin-De Sun, Lin-Lin Zhang, Zheng Wan, et al.
Frontiers in Oncology|October 17, 2022
LASTR is a novel prognostic biomarker and predicts response to cancer immunotherapy in gastric cancerJun-Yan Liu, Jing Yao, Jia-Jia Liu, et al.
Cancer Chemotherapy and Pharmacology|November 22, 2014
Biological evaluation of a novel sorafenib analogue, t-CUPMAaron T Wecksler, Sung Hee Hwang, Jun-Yan Liu, et al.
CNS Neuroscience & Therapeutics|August 15, 2024
Unveiling the shield: Troglitazone's impact on epilepsy-induced nerve injury through ferroptosis inhibitionZhi-Bin Wang, Jun-Yan Liu, Shi-Long Jiang, et al.
Amino Acids|August 4, 2018
Plasma profiling of amino acids distinguishes acute gout from asymptomatic hyperuricemiaYing Luo, Ling Wang, Xin-Ying Liu, et al.
Insects|November 10, 2022
Wound-Healing Effect of <i>Antheraea pernyi</i> Epidermal Growth FactorYu-Lan Piao, Chun-Yang Zhang, Yue Zhang, et al.
Frontiers in Pharmacology|August 28, 2020
The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based ChemotherapyTing Zou, Jun-Yan Liu, Li She, et al.
Cancer Letters|December 20, 2015
Inhibition of mutant KrasG12D-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPMJie Liao, Sung Hee Hwang, Haonan Li, et al.
Biomedicines|December 23, 2023
Role of rs873601 Polymorphisms in Prognosis of Lung Cancer Patients Treated with Platinum-Based ChemotherapyTing Zou, Jun-Yan Liu, Qun Qin, et al.
Investigational New Drugs|February 12, 2008
Evaluation of the therapeutic efficacy of tripeptide tyroserleutide (YSL) for human hepatocarcinoma by in vivo hollow fiber assayXiao-lei Li, Jun-yan Liu, Rong Lu, et al.
Pageof 14